Health Canada approves Moderna’s updated COVID-19 vaccine for Omicron variant
Sep 03, 2022, at 05:03 am
Toronto/IBNS: Moderna’s updated COVID-19 vaccine targeting the Omicron variant has been formally approved by Health Canada.
Moderna sues Pfizer, BioNTech alleging patent infringement over Covid vaccine
Aug 27, 2022, at 02:38 am
Washington/IBNS: Moderna Friday announced to sue its suing rival vaccine makers Pfizer and BioNTech, alleging the partners infringed on its patents in developing their Covid-19 shot, which was administered to hundreds of millions around the world.
UK approves first Covid booster vaccine targeting Omicron variants
Aug 16, 2022, at 12:34 am
London: The UK Medicines and Healthcare products Regulatory Agency said on Monday that it has approved the first COVID-19 booster vaccine developed by US-based pharmaceutical company Moderna that targets original and Omicron strains.
Moderna says its vaccine booster still seems to be effective against Omicron
Dec 21, 2021, at 12:05 am
Moderna, a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, on Monday announced preliminary neutralizing antibody data against the Omicron variant following the Company’s booster candidates at 50 µg and 100 µg dose levels.
Existing RT-PCR tests can detect Omicron variant of COVID-19: Centre
Dec 01, 2021, at 02:56 am
New Delhi/IBNS: Existing COVID-19 tests like RT-PCR and RAT can detect traces of Omicon variant, Health Minister Mansukh Mandaviya told the Parliament amid the scare over the new strain.
Moderna chief warns current vaccines might be less effective against Omicron variant
Nov 30, 2021, at 09:16 pm
New York: Vaccine manufacturer Moderna chief has warned that the currently operating vaccines might be less effective against the Omicron strain of COVID-19 which was first believed to be detected in South Africa.
Moderna studies two booster candidates to anticipate new variant-like mutations
Nov 27, 2021, at 02:07 pm
Washington/UNI/Sputnik: American pharma company Moderna said on Friday it is studying two booster candidates designed to anticipate mutations similar to the Omicron COVID-19 variant discovered in South Africa this week.
India won't buy 'expensive' Moderna, Pfizer Covid-19 shots as local production soars: Report
Sep 22, 2021, at 03:40 am
New Delhi/IBNS: India would not buy Covid-19 vaccines from foreign producers Pfizer/BioNTech and Moderna as domestic production of the shots has increased manifold, Reuters reported citing sources.
Aug 04, 2021, at 01:47 am
New Delhi/IBNS: All US-based Covid-19 vaccine makers are insisting on protection from lawsuits and liability and India is reluctant to allow their entry on these conditions, delaying their availability in India, according to NK Arora, head of the government's vaccine panel.
Moderna's COVID vaccine approved by EU regulator for use on children aged 12-17
Jul 24, 2021, at 04:54 am
The Hague, Netherlands/ IBNS: Moderna's coronavirus vaccine has been approved by the European regulator for use on children aged 12 to 17, making it the second jab to be administered on adolescents in the continent.
Bhutan now has surplus vaccines; US sends 500,000 Moderna vaccines doses
Jul 12, 2021, at 04:35 am
Bhutan has now secured surplus Covid-19 vaccines as the United States confirmed donating 500,000 vaccines to the country. Over 97 percent of the eligible adult population in the country has already received the first dose of vaccine.
India approves US-made Moderna vaccine for emergency use against COVID-19
Jun 30, 2021, at 06:13 am
New Delhi/IBNS: The Centre on Tuesday cleared the fourth vaccine, the US-made Moderna, for emergency use in India.
Moderna and Johnson & Johnson Covid vaccines approved in the Maldives
Jun 08, 2021, at 01:04 am
Authorities in the Maldives have given emergency use approval to Covid-19 vaccines of Moderna and Johnson & Johnson--both of them are already approved by the World Health Organization (WHO).
'Well established' foreign COVID-19 vaccines makers need no bridging clinical trials in India
Jun 02, 2021, at 06:38 pm
New Delhi/IBNS: The Indian government has exempted "well established" foreign COVID-19 vaccines makers from any bridging clinical trials if it has been certified by the National Control Lab of the country where it is made, media reports said.
COVID-19 teen study: Moderna says its vaccine shows 100 percent efficiency
May 25, 2021, at 11:50 pm
Cambridge: Moderna, a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines,on Tuesday announced that the Phase 2/3 study of its COVID-19 vaccine (mRNA-1273) in adolescents has met its primary immunogenicity endpoint, successfully bridging immune responses to the adult vaccination.
US study says Pfizer, Moderna COVID-19 vaccines effective even after first shot in real-world use
Mar 30, 2021, at 03:44 pm
Washignton: A new CDC study provides strong evidence that mRNA COVID-19 vaccines are highly effective in preventing SARS-CoV-2 infections in real-world conditions among health care personnel, first responders, and other essential workers.
Greece weighing production of Moderna, Sputnik V vaccines: Reports
Mar 27, 2021, at 10:56 pm
Athens/Sputnik: Greece is putting out feelers about possible production of Moderna and Sputnik V coronavirus vaccines on its soil, national media reported on Saturday, citing sources.
Moderna delays shipment of about 600,000 doses of COVID-19 vaccine to Canada
Mar 26, 2021, at 11:48 pm
Moscow/Sputnik: Moderna pharmaceutical company has delayed the shipment of about 600,000 coronavirus vaccine doses to Canada due to a lag in the quality control procedure, Canada's Minister of Public Services and Procurement Anita Anand said.
Germany to receive 1st batch of Moderna COVID-19 vaccine on Monday: Health Minister
Jan 12, 2021, at 01:16 am
Moscow/Sputnik: German Health Minister Jens Spahn said on Monday that the first batch of the COVID-19 vaccine developed by the US pharmaceutical company Moderna would arrive in the country later in the day.
Moderna Covid-19 vaccine likely to protect for 'couple of years': CEO Stephane Bancel
Jan 08, 2021, at 05:40 am
Paris/IBNS: Moderna's COVID-19 mRNA vaccine is expected to offer protection of up to a couple of years, the US biotech's chief executive said on Thursday.
Moderna says plans to produce at least 600 million doses of COVID-19 vaccine in 2021
Jan 05, 2021, at 09:05 pm
Moscow/Sputnik: US pharmaceutical company Moderna said it planned to produce at least 600 million doses of its vaccine against COVID-19 in 2021, not 500 million as previously announced.
Oxford vaccine to be 95 pc effective at par with Moderna and Pfizer, says maker AstraZeneca
Dec 28, 2020, at 01:19 am
New Delhi/IBNS: Oxford coronavirus vaccine manufacturer AstraZeneca has claimed that it will shield 95 per cent of the patients and be as effective as Moderna and Pfizer alternatives though the British-Swedish pharma giant is yet to release the data confirming the claim, said media reports.
US: Doctor develops severe allergic reaction after receiving Moderna COVID-19 vaccine
Dec 26, 2020, at 03:24 pm
Boston: A Boston doctor, who has shellfish allergy, developed a severe allergic reaction after taking a shot of the Moderna COVID-19 Vaccine, media reports said.
Moderna expects its COVID-19 vaccine to be effective against mutant Coronavirus
Dec 25, 2020, at 12:15 am
Washington/UNI: US-based pharmaceutical company Moderna expects that its COVID-19 vaccine would be effective against the new strains of the coronavirus that have discovered in the United Kingdom.
US approves Moderna COVID-19 vaccine
Dec 19, 2020, at 02:58 pm
Washington: The United States has approved Moderna's COVID-19 vaccine, paving the way for the release of millions of doses.
Dec 01, 2020, at 04:43 am
Washington/IBNS: Drug manufacturer Moderna has said after full results of a late stage study showed its Covid-19 vaccine has 94.1% effectiveness and no serious safety concerns, it has decided to apply for US and European emergency authorization on Monday, said a Reuters report.
Russia's Sputnik V to be cheaper than Pfizer, Moderna vaccines
Nov 22, 2020, at 10:02 pm
Moscow/UNI: The price per dose of the Russian-made Sputnik V vaccine against coronavirus will be much lower than that of vaccines developed by the US' Pfizer and Moderna pharmaceutical companies, the Russian vaccine's official Twitter account said on Sunday.
Kuwait to receive 1.7 million doses of Moderna Coronavirus vaccine: Reports
Nov 18, 2020, at 10:41 pm
Doha/Sputnik: Kuwait has signed a contract with US company Moderna to receive 1.7 million doses of the COVID-19 vaccine after production begins, Kuwaiti newspaper Al Rai reported.
UK government in talks with US biotech firm Moderna on access to COVID-19 vaccine
Nov 17, 2020, at 01:18 am
London/Sputnik: The UK government said on Monday that it is in advanced discussions to get access to the COVID-19 vaccine candidate being developed by US company Moderna, which, according to the firm, has proved to be nearly 95 percent effective at the clinical trials.
Moderna says its COVID-19 vaccine shows nearly 95 pct efficiency
Nov 16, 2020, at 11:41 pm
London: Moderna, Inc, a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines for patients, on Monday said its vaccine candidate against COVID-19 has shown 94.5 percent efficiency.